Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

Published: 8-Nov-2024
Packaging Regulatory

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack

You need to be a subscriber to read this article.
Click here to find out more.

Fuelled by the expanding global healthcare industry, increasingly ageing populations and advances in available treatments, the pharmaceutical packaging market has seen substantial growth.

This has been reflected in the market value, which is projected to increase from $135.2 billion in 2023 to $284 billion in 2032 at a compound annual growth rate of 7.72%.1 

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

Companies need to stay informed about evolving packaging regulations and adopt best practices to maintain compliance and protect patients; yet, the complexity of the rules and guidelines makes it inherently difficult to navigate this space. Regulatory challenges span various aspects of pharmaceutical packaging. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Tjoapack
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Changes ahead as the US FDA proposes longer national drug codes

Read more
The national drug code (NDC) is a unique number used by the US Food and Drug Administration (FDA) to identify and report drugs

Trending Articles

  1. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    DCAT preview: the future of pharma manufacturing Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
  3. Antares Vision Group to demo high-speed inspection and serialization solutions at Interphex NYC Company will showcase innovations for quality control, traceability, and aggregation of pharmaceutical packaging
  4. AskBio's Parkinson's gene therapy, AB-1005, receives FDA RMAT designation The Bayer subsidiary is currently recruiting for the Phase II REGENERATE-PD trial, which will assess AB-1005's potential in slowing Parkinson's disease progression and improving motor outcomes
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Pharmaceutical method development and validation As analytical methods provide data crucial to ensure consumer health and safety, their validation is highly scrutinised. Dr Joanna Greenhough, R&D Scientist, <strong>Wickham Laboratories</strong>, outlines the best practices in validating methods used in pharmaceutical product testing

Upcoming event

Interphex

1–3 April 2025 | Conference and Exhibition | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Changes ahead as the US FDA proposes longer national drug codes

The national drug code (NDC) is a unique number used by the US Food and Drug Administration (FDA) to identify and report drugs
Packaging

Tjoapack doubles packaging capacity at Netherlands facility

Three production lines have been added, as well as an automated packaging line for vials
Manufacturing

Packaging prefilled syringes: solving the sterility conundrum

What’s the key to ensuring sterility when packaging prefilled syringes?
Packaging

Tjoapack invests $12.1m into Etten-Leur facility

The expansion will see the Tjoapack team almost double with the appointment of more than 100 employees
Packaging

Tjoapack invests in automated injectables packaging capabilities

The packaging lines are projected to be completed by the end of 2021
Packaging

Tjoapack receives investment from Ampersand Capital Partners

Tjoapack has immediate plans to invest in expanding its automated packaging capabilities, including for injectable products, allowing the company to cater to market demand for prefilled syringes and vial packaging
Media

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a number of hurdles and opportunities. A panel of industry experts examine how the slings and arrows of the past twelve months might affect the next ten years
Subscribe now